Biblio

Found 10 results

Author Keyword Title Type [ Year

]

Filters: First Letter Of Title is O [Clear All Filters]

2016

K. Katherine, Julia, B., Valerie, B., Oza, A. M., and Stephanie, L., “Ovarian Cancer and BRCA1/2 Testing: Opportunities to improve clinical care and disease prevention ”, Frontiers in Oncology , vol. 6, no. 00119 , 2016.

2014

F. Collinson, Qian, W., Fossati, R., Lissoni, A., Williams, C., Parmar, M. K. B., Ledermann, J. A., Colombo, N., and Swart, A. Marie, “Optimal treatment of early-stage ovarian cancer.”, Ann Oncol, vol. 25, no. 6, pp. 1165-71, 2014.

2013

D. Handolias, Quinn, M., Foo, S., Mileshkin, L. R., Grant, P., Dutu, G., and Rischin, D., “Oral cyclophosphamide in recurrent ovarian cancer”, Asia Pac J Clin Oncol, 2013.

2011

J. - E. Kurtz, Kaminsky, M. C., Floquet, A., Veillard, A. S., Kimmig, R., Dorum, A., Elit, L., Buck, M., Petru, E., Reed, N. Simon, Scambia, G., Varsellona, N., Brown, C., and Pujade-Lauraine, E., “Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.”, Ann Oncol, vol. 22, no. 11, p. 2423, 2011.

2006

A. du Bois, Schmalfeldt, B., Meier, W., Sehouli, J., Pfisterer, J., OVAR, A. Gynaekolog, Cancer, A. G. O. Study Grou, and Onkologie, N. Gesellscha, “Ovarian cancer–can intraperitoneal therapy be regarded as new standard in Germany?”, Int J Gynecol Cancer, vol. 16, pp. 1756-60, 2006.

2004

S. Pignata and Vermorken, J. B., “Ovarian cancer in the elderly.”, Crit Rev Oncol Hematol, vol. 49, no. 1, pp. 77-86, 2004.

2003

M. A. Bookman, Greer, B. E., and Ozols, R. F., “Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5”, Int J Gynecol Cancer, vol. 13, pp. 735-40, 2003.

M. A. Bookman, Greer, B. E., and Ozols, R. F., “Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel versus cisplatin and paclitaxel (GOG158) and an update on GOG0182-ICON5.”, Int J Gynecol Cancer, vol. 13 Suppl 2, pp. 149-55, 2003.

2000

J. B. Vermorken, “Optimal treatment for ovarian cancer: taxoids and beyond.”, Ann Oncol, vol. 11 Suppl 3, pp. 131-9, 2000.

I. B. Vergote, “Organization and ethical aspects of randomized trials in gynecologic oncology”, Verh K Acad Geneeskd Belg, vol. 62, pp. 385-95; discussion 395-8, 2000.